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Abstract
Chronic diseases are heavily taxing the American health system. The federal
government has implemented new laws, such as the Affordable Care Act (ACA), in order to
increase American wellness at no additional cost and to reduce the significant financial burden.
Considering the enactment of ACA and cost cutting, it’s an opportune time to explore new
approaches to delivering high quality patient care before the start of a disease. Preventative
health wellness clinics can serve this purpose. However, preventative care clinics are not
without challenges. Modifying patients’ behaviors have proven to be difficult and no research
literature exists to provide an evidence-based approach which has a proven record in changing
poor patient habits. However, if focus is placed on patients who are at increased risk for
developing a chronic illness and tests favorable for behavior modification, the ideal preventative
health clinic may set the stage for improved healthcare outcomes and cost reduction.

I. Background
a. Patient Protection and Affordable Care Act
The institution of the Patient Protection and Affordable Care Act (PPACA) of 2010 or
Affordable Care Act (ACA) has set the stage for a new paradigm in the delivery of healthcare in
the United States (U.S.). Not only the law attempts to ensure every American has health
insurance, it also strives to reduce the rising cost of healthcare. To address the rising cost, the
ACA outline important preventive services for Americans. The goal is to avoid preventable
illnesses and to improve health at no additional cost to the patient. Covered services include
screening and counseling for alcohol abuse, blood pressure, diet, obesity, tobacco use, and
cholesterol (DHHS, 2013).
In addition to providing benefits to patients, ACA also provides perks for clinicians as
well. Of particular interest are benefits relating to preventative care. The creation of new models
of care coordination and increase health coverage, opens the door to exploring opportunities in
preventative medicine and care. For example, in conjunction with ACA, the American Recovery
and Reinvestment Act of 2009’s healthcare information technology objectives offer opportunities
to receive patient information faster and exchange it electronically with other healthcare
providers. Also, with an increase insured population and the desire to bulk up preventative care
services, new business models can be entertained (i.e. preventative healthcare and wellness
clinics). There is much to be gain from these laws in addition to the excitement of partaking in
reducing the astronomical cost of America’s healthcare.
b. Cost of Healthcare and Top Diseases/Conditions
To take advantage of the PPACA preventative care benefits, it’s noteworthy to review
the cost breakdown of salient diseases afflicting America’s population today. America’s national
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health expenditure as a percent of gross domestic product (GDP) has continually increased
from 16% in 2005 to a projected 19.8% in 2020 (CMS, 2011). Comparatively, other Organization
for Economic Co-operation and Development (OECD) countries averaged 9.5% of GDP (2012).
This has raised many concerns for policy makers as they try to curb the costs of healthcare. For
example, chronic diseases comprise 75% of healthcare spending (CDC, 2011). Most
individuals are at the age of 65 and over, comprising 13% of the U.S. population. However, in
2002, this age population consumed 36% of healthcare expenses (AHRQ, 2006). This prompts
the need for better prevention and treatment practices for chronically ill patients. (Please see
Appendix A for charts and graphs.)
The top ten most expensive chronic illnesses, in order, are heart conditions, traumarelated disorders, cancer, mental disorders, chronic obstructive pulmonary disease (COPD)
including asthma, osteoarthritis, diabetes mellitus (DM), hypertension, back problems, and
hyperlipidemia (AHRQ, 2010). Obesity related healthcare costs are closely linked to many of the
top ten conditions (Finkelstein, Trogdon, Cohen, & Dietz, 2009). For the purposes of our
preventative healthcare clinic, we will focus efforts on addressing the current top six chronic
diseases/conditions affecting Americans. They are heart disease, stroke, mental disorders,
chronic obstructive pulmonary disease (COPD) & asthma, diabetes, and obesity. These
diseases are most amenable to lifestyle changes and prevention strategies.
Heart disease and stroke are widespread conditions affecting many Americans and
costing the U.S. health system billions of dollars each year. According to an AHRQ panel
survey, heart conditions are America’s most expensive medical condition, totaling $107 billion
per year (AHRQ, 2010). Heart disease is the leading cause of death for both men and women.
The Centers for Disease Control and Prevention (CDC) reports 600,000 people die of heart
disease every year (CDC, 2013). Similarly to heart disease, stroke also contributes its share of
over burdening America’s healthcare. The CDC estimates $38.6 billion per year is spent on
handling patients with this disease (CDC, 2013). Stroke is considered the 4th leading cause of
American deaths, killing 130,000 per year (CDC, 2013). The disease is also the leading cause
of disability among U.S. adults, and requires a heavy expense.
Mental disorders also add a financial burden to America’s health system. In 2010, $73
million was spent on treating mental disorders. However, for the purpose of the proposed ideal
clinic, depression will be the primary focus. Depression has established correlations to other
chronic diseases and is the most prevalent mental health illness amongst older adults (Welch,
Czerwinski, Ghimire & Bertsimas, 2009). In 2009, $22.8 billion was spent on the treatment of
depression and another $17 to $44 billion was spent because of lost workdays. In a given year,
18.8 million adults will suffer from a depressive illness (CDC, 2011). Finally, depression is also
the principal cause of the 30,000 suicides occurring each year.
In 2010, $49.9 billion was spent on managing COPD patients. Of that, over 55% of the
cost results from complications such as emergency room visits and hospitalizations. COPD
affects 13.1 million US adults, but another 24 million have evidence of impaired lung function.
COPD is largely preventable, as smoking is the primary risk factor (causing approximately 85-
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90% of COPD deaths). Lag times between tobacco exposure and disease development mean
that the prevalence of COPD will continue to rise (American Lung Association, 2011).
In 2007, $56 billion in total was spent on treating asthma. The disease affects 25.9
million Americans, of which 13.2 million had an asthma attack in 2011. Asthma accounted for an
estimated 14.2 million lost work days, and for 2.1 million emergency visits. Although the cause
of asthma is not well understood, the ability to prevent exacerbations can result in huge cost
savings (American Lung Association, 2012).
Diabetes treatments cost Americans over $51 billion in 2010. DM is the seventh leading
cause of death in the United States and it is the leading cause of kidney failure, lower limb
amputations, heart disease and stroke. There are 25.8 million Americans (8.3% of the US
population) that have diabetes (NIH, 2010). The mortality rate among people with diabetes is
double the rate among non-diabetic people within the same age group (NIH, 2010).The
estimated number of Americans who are at risk for diabetes is 79 million. However, only 11%
are aware they are at risk for developing DM (Reinberg, 2013).
The sixth disease the proposed clinic will address is obesity. According to data from the
National Health and Nutrition Examination Survey, between 2009 and 2010, over 78 million U.S.
adults and about 12.5 million U.S. children and adolescents were obese (Ogden et al, 2012).
America’s Health report (2012) states obesity can result in four common high-cost health
problems: Type 2 diabetes, coronary heart disease, stroke, hypertension, and obesity-related
cancers. Obesity-related healthcare costs approximately $117 billion annually. More than one
quarter of U.S. healthcare costs are related to physical inactivity, overweight, and obesity.
Therefore, it is important to prevent the occurrence of obesity, to prevent further consequences,
and to reduce the healthcare cost for preventable health problems.
c. Description and Goals for Preventative Healthcare Clinic
Primary care is key to prevention and treatment of the aforementioned top chronic
illnesses but unfortunately, the primary care system is suffering. Phillips & Bazemore (2010)
review the history and current situation of primary care in the United States. It has been stated
that due to the lack of a primary care centered healthcare system, the U.S. is falling farther
behind in population health metrics. Furthermore, there is a huge gap in the U.S. physician
workforce for primary care. Most physicians enter into subspecialty residencies because of the
desire to land higher paying jobs in urban area hospitals. Still, primary care represents the
greatest platform for formal healthcare – totaling 57% of all patient visits. Despite the volume of
care, it is estimated to be only 6-7% of total healthcare spending for Medicare beneficiaries. The
proposed prevention-oriented clinic captures the opportunity to address primary care needs,
improve patient outcomes, implement innovative prevention strategies, and provide an
integrative patient-centered solution for patients.
In recognition of the benefits of primary care, the increasing costs of healthcare and the
shortage of primary care physicians, we suggest a prevention-oriented clinic. This clinic will
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target its resources toward populations at highest risk for the six chronic illnesses; having high
capability for changing their individual behaviors; and adhering to recommended prevention or
treatment guidelines. In this paper, we discuss the current literature on risk assessment for the
target diseases and theories on change behavior. We hope to incorporate our findings to create
a resource allocation matrix that will serve as a clinical decision support tool to separate patients
into cohorts for different levels of intervention.

II. Literature Review
a. Heart Disease and Stroke
Heart disease and stroke risk factors are fairly well known because of organizations
such as the American Heart Association (AHA) and federal programs stemming from the Joint
Commission. Americans are educated about proven key risk factors contributing toward
increasing susceptibility for developing heart disease and stroke (e.g., weight/body mass index
(BMI), diet, exercise, blood pressure, alcohol consumption, smoking status, and cholesterol).
Short risk assessment questionnaires are found throughout the Internet asking individuals to
enter their most recent blood pressure, weight, and cholesterol readings. These tools typically
free and calculate the risk scores based on the information entered by the end user. These tools
do not serve as diagnosis, but rather educate patients about their risks. However, of particular
interest is AHA’s website which includes a risk assessment tool as described in addition to their
Get with the Guidelines tools for heart disease and stroke. These tools can be utilized for our
preventative healthcare clinic. However, Gillespie and Lenz warns, although 70% of strokes and
80% of heart disease are preventable, behavior change is the limiting factor (Gillespie & Lenz,
2011). Therefore, our clinic will need to determine effective behavior modification tools and
methodologies which could lead to effective change.
b. Mental Illnesses and Depression
Depression is one of the most prevalent of mental disorders and has strong risk factors
for developing other chronic conditions and vice versa (Rubin, 2011). There are many screening
tools that are easily accessible and available for general mental illness and depression, but no
risk assessment tool for developing mental illness or depression is available. A meta-analysis
conducted by Gilbody, Sheldon, & House (2008) suggests that at present early detection does
not change primary care treatment or hospital treatment, possibly resulting in little to no change
in patient outcomes (O’Connor, Whitlock, Beil, Bradley, & Gaynes, 2009). It may be that early
treatment for mental illnesses and depression is not yet well developed, thus early detection has
little benefit. Klein, Glenn, Kosty, Seeley, Rhode, & Lewinsohn (2013) found the predictors for
depression for young adults were female gender, anxiety disorder before age 18, family history
of mood disorder, sexual abuse during childhood, subthreshold depressive symptoms, and poor
physical health. Their study acknowledged that a creation of a risk assessment tool is needed
and would be of benefit to at-risk youth.
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c. COPD and Asthma
The current assessment for COPD is to get the patient history on tobacco smoking,
other inhalation exposures (such as occupational dusts or chemicals, air pollution, and/or
passive exposure to smoking), and familial tendency for COPD. Genetic testing for alpha-1
antitripysin deficiency is rare but a significant risk factor for COPD (COPD CPM Workgroup,
2013). The main assessment tools for COPD are to assess the stage of disease or the current
patient condition. There are no specific tools developed to assess risk of developing COPD, so
clinicians will have to be thorough in their patient history assessments (Ohar, Sadeghnejad,
Meyers, Donohue & Bleecker, 2010).
Despite the nearly 22 million people in America being affected by asthma, the etiology of
the disease is not well known therefore current research cannot state assuredly what risk
factors are the best predictors of disease (Subbarao, Mandhane, & Sears, 2009). It is
understood that there is some gene-environment interaction that triggers the disease (Subbarao
et al., 2009; Blumenthal, 2012). Some risk factors that have been associated with asthma are:
prenatal maternal smoking, prenatal maternal antibiotic use, different types of infant and
childhood wheezing, reduced airway/lung function in infancy, childhood antibiotic use, higher
levels of immunoglobulin E at birth, infant and childhood exposure to tobacco smoke, particular
occupational exposures, and smoking tobacco/marijuana (Subbarao et al., 2009). Asthma
triggers and severity varies significantly (Subbarao et al., 2009). This has led researchers to
develop assessment tools based on patient reported conditions and lung function tests. The two
most prominently used risk assessment tools for asthma exacerbation are the Asthma Control
Test (ACT) and the Asthma Control Questionnaire (ACQ) (Jia et al., 2012).
d. Diabetes
There are several screening methods for type 2 diabetes, such as oral glucose tolerance
test (OGTT), hemoglobin A1c (HbA1C), fasting plasma glucose (FPG), family history of diabetes
(FHD), and body mass index (BMI). Some of these tests are expensive and time consuming.
Norberg et al (2006) examined the effective and more accurate screening methods, and found
that the combination of HbA1c, FPG and BMI are effective in screening for individuals at risk of
future clinical diagnosis of type 2 diabetes, while the OGTT or FHD is not necessary (Norberg et
al, 2006). The Finnish Diabetes Risk Score (FINDRISC) is a well-established tool and
recommended for evaluation of the risk of Type 2 diabetes. The FINDRISC tool includes
assessing the biomedical marker and the diabetes risk genetic marker. A study by Wang,
Stancáková, Kuusisto, and Laakso shows that biochemical markers, but not genetic markers,
improve the identification of previously undiagnosed type 2 diabetes (Wang et al., 2010). The
Canadian Task Force on Preventive Healthcare conducted a study to identify a screening model
that predicts high risk of future Type 2 diabetes and is useful in clinical practice. The study
shows that management of other cardiovascular risk factors, such as dysglycemia, during
diabetes risk screening is required. The examiner should consider obesity, physical inactivity,
tobacco use, hypertension, and dyslipidemia in individuals with diabetes to give better prediction
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about the likelihood of developing diabetes in the future (CMAJ, 2012). (See figure 11-14 in
Appendix B.)
e. Obesity
Obesity has its own set of risk factors, but is also a major risk factor of other diseases
such as diabetes, heart disease, stroke, hypertension and cancer (America’s Health, 2012).
One projection model from the Robert Wood Johnson Foundation (Healthy Americans, 2012)
suggests that if obesity rates continue on their track, the number of new cases of type 2
diabetes, coronary heart disease and stroke could increase 10 times between 2010 and 2020–
and double again by 2030. Obesity could contribute to more than 6 million new cases of Type 2
diabetes, 5 million new cases of coronary heart disease and stroke, and more than 400,000 new
cases of cancer in the next two decades. However, if the average BMI is reduced by five
percent, the number of cases would decrease dramatically and would save up to $81.7 billion
(Healthy Americas, 2012).
Some risk factors for obesity include genetics, inactivity, unhealthy diet, family lifestyle,
smoking, certain medications, socioeconomic status, and other medical problems (Hebebrand &
Hinney, 2009). Several studies recommend using the body mass index (BMI) as a reliable tool
in screening overweight and obesity (NHLBI, 1998). (See figure 15 in Appendix B.) (Please see
Table 1 in Appendix C for comparison of risk assessment tools.)
III. Findings
a. Preventative Healthcare Clinics
A Google search turned up limited number of Preventative Care clinics in existence
today (i.e., Born Preventative Health Care Clinic, Samsum Clinic). The fascinating fact about
this search is California appeared to be well represented. For example, their Preventative
Medical Center of Marin clinic provides some clues to the success of such clinics and the
population needs. The center was founded by Dr. Elson M. Haas in 1984. His center blends
traditional western and eastern therapies. It is evident his clinic is promoting wellness and
attempting to prevent illness. Dr. Haas appears to be very successful, having authored several
books and conducted speaking engagements throughout the country. The Marin Center
provides services for managing chronic diseases/conditions such as asthma, hypertension, and
diabetes (PMCM) in addition to wellness.
It is unclear whether the center uses behavior and risk assessment tools as part of their
patient care practices. The idea of utilizing behavior modification and risk assessment tools may
set our clinic apart from the competition in addition to achieving greater results with getting
patients to remain compliant and vigilant.
b. Prevention Theory
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According to Leavell and Clark (1965) the classifications of preventative strategies are:
1) Primary prevention are behaviors that maximize well-being and to avoid disease. The
person does not have any diagnosable diseases is not in any high risk group. For
example, A person exercises 3 times a week and meditates regularly to maintain health
and manage stress.
2) Secondary prevention are behaviors that forestall the risk factor into developing into a
serious disease. The person has a diagnosable risk factor, but not a definitive disease
that will cause direct harm. For example, A person eats low cholesterol foods because
currently has elevated cholesterol levels and takes statin medications. But this person
would not immediately develop disease nor does the disease really affect their
functioning.
3) Tertiary prevention is to prevent the progression of a disease. The person has a disease
that affects theirs functioning and now are taking steps to slow progression, prevent
complications, and death. For example, a person has developed cancer and now goes
to all chemotherapy appointments on time, as scheduled, and follows all instructions to
prevent infections.
c. Behavior Modification and Tools
Our literature review showed that there are some commonly used behavior change
theories used by researchers and practitioners in designing intervention programs for some
cases such as obesity, hypertension, DM type 2 (Gillespie & Lenz, 2011). Behavior change
theories help us understand individuals’ behaviors and design the intervention program.
(Hildebrand, 2010). The most applied model is the Transtheoretical Model and Stages of
Change. There are only a limited number of change behavior assessment tools that have been
developed from these theories, as it is difficult to create questions specific for disease types that
consistently prove valid, sensitive and specific.
However, a non-traditional tool to consider for heart and stroke patients is genetic
susceptibility testing. Vassy, et al. (2013) discussed this tool for assessing patients’ tendencies
to change behaviors if they are identified as high risk for developing heart disease and/or
diabetes. Their study particularly honed into the young adult population (between 25 and 30
years old). Although possibly promising, the study’s results were mixed and therefore, did not
provide solid evidence that young adults may be motivated to change if they are identified as
high risk. Despite this issue, the tool can be used to assess a younger generation for disease
development for our proposed health clinic (Vassy et al., 2013). The best times to start
developing good habits is to start early. If individuals are taught at a young age about the
importance of diet, physical activity, and not smoking, this can contribute to lowering the total
numbers of patients affected by heart disease/stroke. (Please see Table 2 and Table 3 in
Appendix C for list of behavior change theories and assessment tools.)
IV. Recommendations
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a. Overall Assessment
Patient reported outcome (PRO) surveys have been used in research to obtain a quick
but thorough understanding of the patient’s health condition. We reviewed several health PRO
surveys and the most thoroughly developed, technologically advanced, and easiest to use for
patients would be QOLIX which is developed by the John Ware Group.

b. Heart Disease, Stroke, Diabetes, and Obesity
The recommended risk assessment for heart disease or stroke is the simple
questionnaires provided by American Heart Association (AHA). DM and obesity also share
similar risk factors and are themselves risk factors for heart disease and stroke therefore the
questionnaire from the AHA is the recommended risk assessment tool. If the patient is between
the ages of 25-30 year old, the genetic susceptibility testing tool may be reasonable considering
these patients may be more willing to change if they discover he/she is ask risk for a deadly
and/or debilitating disease. Primary prevention for these diseases involves diet and exercise
(Reinberg, 2013). Secondary prevention are screening tools, and tertiary would be disease
management guidelines provided by the AHA, and American Diabetes Association, which would
also involve following a healthy diet, regular exercise, and medication regime (AACE, 2011).
The recommended screening tools for DM are HbA1c blood tests. The recommended screening
tools for both heart disease and stroke are to use the tools provided by the AHA’s Get with the
Guidelines for HF/Stroke and AHA’s short heart disease risk calculator. AHA’s website has a of
wealth information on heart disease and stroke. The knowledge should be leverage when caring
for our clinic patients. There is no need to reinvent the wheel because their effectiveness have
been proven and repeatedly used throughout the medical community. (See Figure 16, 17 in
Appendix B.)
c. Mental Illnesses and Depression
Overall the easiest to use, most studied, and cheapest depression screening tool is the
Patient Health Questionnaire-2 (PHQ-2). It only has 2 items, free to use, easy to score, studied
in primary care settings, and has proven to be sensitive, valid, and specific. The recommended
screening tool for overall mental health is the M3 Checklist, it has also been studied in primary
care settings and is free to use. There is not enough knowledge to create primary prevention
strategies other than physical activity and healthy diet, for secondary prevention would be the
use of these screening tools, and tertiary prevention also requires more research to determine
how to prevent mental illness complications. (See Figure 18 in Appendix B.)
d. COPD and Asthma
Research in developing a scoring system to measure risk of developing COPD would be
helpful to clinicians. Primary prevention would involve smoking cessation programs, as smoking
is the primary risk factor for developing COPD. Screening those who smoke frequently with
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stage testing could be used as a secondary prevention. Tertiary prevention would include close
monitoring of symptoms with staging, and adherence to COPD disease management program.
It is not suggested to screen patients for COPD that do not have a history of smoking or other
risk factors as studies have shown a high false-positive result from spirometry testing in those
over the age of 70 (US Preventive Services Task Force, 2008). Management of disease and
exacerbations should follow GOLD recommendations as they are the most up to date, most
supported by research, and represent the standard of care (GOLD, 2013). (See Figure 19 in
Appendix B.)
Current understanding of asthma does not identify the cause of the disease,
associations of prenatal, infant, and childhood exposures to controllable behaviors are important
considerations for primary prevention. Tertiary prevention would include risk assessment for
asthma attacks. The NHLBI do not make specific recommendations on which asthma
exacerbation risk assessment to use. All the questionnaires are easy to administer and the
meta-analysis review for the ACT and ACQ reveal similar validity (Jia et al., 2012). The major
difference would be that the ACQ was developed specifically for clinical use and therefore would
be our recommendation as the risk assessment for tertiary prevention strategies. Recent studies
have shown promise in the value of exhaled nitric oxide as predictor of loss of control of asthma
but further investigation of feasibility and costs to implement in a primary care clinic before
would be needed before recommendations for its use could be made (Ozier, Girodet, Bara,
Tunon de Lara, Marthan, & Berger, 2011). (See Figure 20 in Appendix B.)

V. Application to the Design of the Preventative Healthcare Clinic
a. Recommended Behavior Modification Models and Tools
University of Rhode Island Change Assessment Scale (URICA) was the only scale one
that was not disease specific and considered the four stages of change as described by the
transtheoretical model of change – precontemplation, contemplation, action, and maintenance.
Many change behavior scales were tailored to substance use or addictions patients and not well
studied for other health behavior changes. Therefore we recommend the URICA scale. Gillespie
& Lenz (2011) suggest that the data from completed questionnaires should be used by the
clinical staff to determine which behaviors to address first, help set patient-driven goals,
determine what the patient is not interested in changing, and to help determine the participant’s
stage of readiness to consistently participate in a behavior. (See Figure 21 in Appendix B.)
Although in our literature review we were unable to find any tools that assess social
environment as predictors of change, many chronic illnesses are affected by socioeconomic
factors. It would be prudent for clinicians to understand the socioeconomic barriers that prevent
behavior change.
b. Proposed Clinic High Level Definition Model
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Level

Sections

Purpose or Function

1

Greeter &
Triage (at clinic
entrance)

Greet each patient, listen to his or her need, capture chief
concern/complaint, and explain next step(s). For new patients,
guide him/her to registration computer terminals. Established
patients will be registered upon greeting the client. This is staffed
by one unit secretary that can also flex to the family room if
needed. (Estimated time less than 2 minutes.)

2

Family Room
(center of the
clinic)

This area is the patient registration, waiting area, and education
area. New patients will complete full registration including contact,
past and current medical information, reason for visit, and
insurance at the computer terminals. The family room will have 68 computers around a center table for registration and learning
material. Established patients can quickly update their information
if needed. This is staffed by one unit secretary that can also flex to
the Greeter/Triage area if needed. (Estimated 5-10 minutes for
established patients, 10-15 minutes for new patients.)

3

Level 1
Assessment
(desk with
privacy
partitions) x 2

For new clients only. A Licensed Practical Nurse (LPN) will give
an overview of the clinic, the scope of practice, services, and
costs. The patients will take the QOLIX online assessment and
URICA. The LPN will review the results with the patients and
evaluate the patient’s needs in relation to the results. The LPN will
escort patient with all the results to a private exam room for the
level 2 assessment. This is staffed by 2 LPNs. (Estimated 15
minutes.)

4

Level 2
Assessment
(private exam
rooms) x 3

For new clients only. The RN will complete (1) detailed disease
specific assessments for staging and screening. Depending on the
results from the QOLIX of what diseases clients are at risk for will
determine the number of assessments that needs to be completed
by the RN. The RN will also complete (2) basic physical exam
such as vital signs, blood glucose (at risk diabetes), height,
weight, calculate BMI, waist circumference, and other necessary
measurements. RN will also (3) calculate care plan resources
dependent upon client’s URICA score and risk score mapped onto
the resource allocation matrix. If risk score not available, then use
QOLIX score. This is staffed by 3 RNs. (Estimated 20-30
minutes.)

5

Care Planning
Team

For new clients, dependent upon the resource allocation matrix,
the appropriate individualized care plan will be created and then
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(same private
exam rooms as
Level 2
Assessments) x
3

reviewed with the client by the care team. Dependent upon the
results the care team may consist of a Nurse Practitioner(NP)
and/or a Physiotherapist (PT) and/or a Registered Dietician (RD)
and/or Social Worker (SW) and/or other alternative therapy
practitioners. They may also refer patients to specialists for further
disease management. The physician will work collaboratively with
the three teams. With established patients, their role will be more
supervisory as the care planning team will mainly be responsible
for the client’s care management. The care team will also
schedule the next appointment if needed. (Estimated 20-30
minutes). This is staffed by 3 teams.
For established patients, the care team member(s) will review
client progress and current reported condition/concerns. Not every
appointment will require the entire care team. The care plan will
be adjusted as needed. (Estimated 10-20 minutes.)
The cycle time for new clients is estimated between 60-90
minutes. The cycle time for return clients is estimated between 2030 minutes.

Prevention requires holistic and integrated treatment for patients thus it is important to
have easy access to the other necessary services for prevention. These include a fitness studio
for activity promotion, pharmacy and related medical devices, foods that promote healthy eating,
and areas for relaxation and mental wellness. Ideally these services would be operated in
conjunction with the clinic to provide a “one-stop shop” center for clients. The diagram below
would be ideal to provide easy access to related healthy behaviors other than medical
assessments. (Please see Appendix D for clinic map and high level process map.)

Clinic map in relation to other services
Resource Allocation Matrix
As stated in earlier, the goal of this paper is to devise a clinical decision support tool to aid
clinicians in placing patients in cohorts to maximize effectiveness by determining how to allocate
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limited resources. The resource allocation matrix below combines the URICA change behavior
assessment and the QOLIX or specific disease risk score to determine who are the most at risk
and who are most amenable to change. This cohort would require the focus of resources to
prevent disease development and high healthcare costs for the future.

Resource allocation matrix
c. Rationale
In the attempt to apply our knowledge from the literature review and class material into a
prevention-oriented clinic, we needed to design a process and space that limited waste whilst
still accomplishing the layers of assessments. The initial assessment of a new patient is a
lengthy process, but we did try to limit the use of resources by assigning tasks to the least
skilled person possible, leaving only the complex disease management to the case team. In our
design the physician oversees many case teams so as not to rely too heavily on physicians, as
there is a large primary care physician shortage. For return patients, the process is fairly
straightforward with easy greet and registration process, then onto see the care team, with
possible wait time at the family room with the educational material.

VI. Conclusion
In conclusion, with the enactment of ACA, the landscape for preventative medicine is
transforming. This is an ideal time to explore new approaches to care delivery and bring
preventative care to the forefront. Current data shows that the majority of spending is directed to
disease management, while there is less than 1 % going to preventive care. Chronic diseases
consume a large portion of the healthcare budget, but this can be avoided by early detection
and providing good preventive care for individuals at risk. The need to allocate resources wisely
and ethically requires the assessment of two aspects when interviewing a new client, risk and
compliance. Individuals who are at risk and show high level of changeability should receive the
most resources. If a client has low level of readiness, education would be provided and the
client would be reassessed. The overall aim is to improve the health of our community; we
believe our clinic will set a new paradigm for preventative and wellness care clinics.
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